In summary, the CRISPR/Cas9-generated PLB-985 NCF1 ΔGT cell line fully recapitulates the genetic background and functional NADPH oxidase defect found in majority of p47phox-deficient CGD patients, can be corrected genetically and differentiated into functional neutrophils. The gene discussed is FMO5; the disease is chronic granulomatous disease.